Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Sep 3;12(9):2491. doi: 10.3390/cancers12092491

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Promising strategies to improve the efficacy of PDT for PCAR. Promising results from the application of PDT for PCAR have been achieved using innovative photoimmunoconjugates and photosensitizer-loaded nanocarriers, which can in principle be combined to develop targeted photonanomedicines. Regarding the integration into the clinical practice, PDT may synergize with clinical chemotherapies, and innovative lighting solutions (e.g., implantable light panels and diffusing tip laser wands) may aid in improving the efficacy of PDT for PCAR. To overcome the difficulty of reaching occult PCAR with light, radiotherapy-activated PDT may be a promising solution.